We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 8,974 results
  1. In Vitro and In Silico ADME Prediction

    Pharmacokinetic issues have been identified as a major cause for the attrition of new chemical entities in drug discovery. High development costs and...
    Angela Effinger, Caitriona M. O´Driscoll, ... Nikoletta Fotaki in ADME Processes in Pharmaceutical Sciences
    Chapter 2024
  2. Blood Flow Distribution and Membrane Transporters as Determinant Factors of Tissue Drug Concentration

    The free drug hypothesis states that the non-ionized free drug concentrations will have the same value in all the aqueous spaces of the body, once...
    Pietro Fagiolino, Alan Talevi, ... Manuel Ibarra in ADME Processes in Pharmaceutical Sciences
    Chapter 2024
  3. Introduction: Biopharmaceutics and Pharmacokinetics

    Biopharmaceutics and Pharmacokinetics are pharmaceutical disciplines that are useful for improving the outcome of drug therapies, assisting drug...
    Alan Talevi, Pablo A. Quiroga in ADME Processes in Pharmaceutical Sciences
    Chapter 2024
  4. Drug-Drug and Food-Drug Interactions of Pharmacokinetic Nature

    The most relevant pharmacokinetic mechanisms of drug-drug (DD) and food-drug (FD) interactions are summarized from a perspective that will allow the...
    Pietro Fagiolino, Marta Vázquez, ... Rosa Eiraldi in ADME Processes in Pharmaceutical Sciences
    Chapter 2024
  5. Advanced Techniques for Quality Assessment of Nanocarriers

    Nanoparticle characterization is crucial for develo** and optimizing nanocarriers, as it is necessary to have a comprehensive understanding of...
    Jordano Cichelero Facchini, Anamaria Mendonça Santos, ... Luiza Abrahão Frank in ADME Processes in Pharmaceutical Sciences
    Chapter 2024
  6. Regulatory Requirements and Applications of Physiologically Based Pharmacokinetic Models

    Physiologically based pharmacokinetic (PBPK) models have become a key tool to reduce the uncertainty and assure the best benefit-risk decisions in a...
    Marina Cuquerella-Gilabert, Matilde Merino-Sanjuán, ... Javier Reig-López in ADME Processes in Pharmaceutical Sciences
    Chapter 2024
  7. Vaccine Safety Surveillance

    Vaccine safety surveillance is an essential component of public health initiatives to assure the safety and effectiveness of vaccination programs....
    Mohd Amir, Mukesh Nandave, Anoop Kumar in Pharmacovigilance Essentials
    Chapter 2024
  8. Reporting of ADRs Across the Globe: India, USA, EU, and Non-EU

    This chapter conducts a comparative analysis of adverse drug reaction (ADR) reporting practices in four prominent global regions: India, the United...
    Priyanka Sharma, Mukesh Nandave, Anoop Kumar in Pharmacovigilance Essentials
    Chapter 2024
  9. Impact of Aging, Lifestyle, and Phytochemicals on the Commencement of Neurological Disorders

    Neurodegenerative diseases (NDs) are examples of neurological disorders. Common NDs include Alzheimer’s disease (AD), Parkinson’s disease (PD),...
    Hadeer M. Hamdalla, Mohamed Y. Zaky, Manal Abdul-Hamid in Neuroprotective Effects of Phytochemicals in Brain Ageing
    Chapter 2024
  10. Bioactive Compounds of Algae: Potential Neuroprotective Agents in Neurodegenerative Disorders

    Neurodegenerative diseases are diverse in nature and are characterized by the continuous loss of neurons, glial cells, and neural networks in the...
    Sripriya Paranthaman, Paheshwari Palraj in Neuroprotective Effects of Phytochemicals in Brain Ageing
    Chapter 2024
  11. The Controversy Surrounding Drugs Against Neurodegenerative Disorders: Benefit or Harm?

    The global healthcare system and public health are burdened by Alzheimer’s, Parkinson’s, and Huntington’s diseases. Due to their increasing...
    Priyadarshini Roy, Dibyajyoti Ghosh, ... Abhijit Dey in Neuroprotective Effects of Phytochemicals in Brain Ageing
    Chapter 2024
  12. Phytochemicals as Protective Agents for Brain Aging

    Aging is the major danger agent for many age-related disorders, including neurological diseases. Knowing the biological mechanisms of aging is...
    Mohamed Y. Zaky, Hadeer M. Morsy, Osama M. Ahmed in Neuroprotective Effects of Phytochemicals in Brain Ageing
    Chapter 2024
  13. Neurotrophins and Phytochemicals: Potential Partners to Combat Neurodegenerative Diseases

    Neurotrophins and phytochemicals have emerged as promising areas of research in the field of neuroscience and human health. Neurotrophins are a group...
    Megala Jayaraman, Annesha Dutta, ... Hanumanth Rao Balaji Raghavendran in Neuroprotective Effects of Phytochemicals in Brain Ageing
    Chapter 2024
  14. Microfluidics Integrated Biosensors: Design, Fabrication, and Testing

    Microfluidic systems have been quite thoroughly discussed throughout this chapter book, though it is through biosensors that such systems reveal...
    Brandon Daniel Tipper, Maciej Marian Filicha, ... Mohammad Nasr Esfahani in Microfluidics in Pharmaceutical Sciences
    Chapter 2024
  15. Applications of Microfluidics in Cancer Diagnosis and Treatment

    Cancer is one of the leading causes of mortality globally, with a possibility to prevent many of these incidents via enhancing lifestyle habits and...
    Bader Kharaibet, Edward Weaver, Dimitrios A. Lamprou in Microfluidics in Pharmaceutical Sciences
    Chapter 2024
  16. Microfluidic Production of Inorganic Nanoparticles

    Inorganic nanoparticles (NPs) have considerable potential for biomedical applications, such as drug delivery, cancer imaging, and cell tracking....
    Ze Song, Muhammad Shafiq, ... Ming Ma in Microfluidics in Pharmaceutical Sciences
    Chapter 2024
  17. Microfluidic Technologies for Precise Drug Delivery

    There is a current demand for new and more sophisticated drug delivery systems (DDSs) to efficiently deliver therapeutics to the desired tissues,...
    Bárbara Ferreira, Paulo Faria, ... Cláudia Martins in Microfluidics in Pharmaceutical Sciences
    Chapter 2024
  18. Microfluidic Point-of-Care Devices

    The provision of healthcare has been revolutionized by the development of microfluidic point-of-care (POC) devices as revolutionary tools in medical...
    Vedika Khare, Arpana Parihar in Microfluidics in Pharmaceutical Sciences
    Chapter 2024
  19. Nanocarriers: Delivery Routes

    Nanocarriers have crucial applications in medicine, mainly in drug delivery. The choice of administration route assumes significance during the drug...
    Andrey Silva Morawski, José Adão Carvalho Nascimento Júnior, ... Luiza Abrahão Frank in ADME Processes in Pharmaceutical Sciences
    Chapter 2024
  20. The Relationship Between Pharmacogenomics and Pharmacokinetics and Its Impact on Drug Choice and Dosing Regimens in Pediatrics

    The concept of precision or personalized medicine in pediatrics is still in its infancy, and it is difficult to conduct clinical studies in...
    Jessica K. Roberts, Leslie Escobar, Catherine M. Sherwin in ADME Processes in Pharmaceutical Sciences
    Chapter 2024
Did you find what you were looking for? Share feedback.